Gold Carding, a practice in healthcare where payers waive prior authorization requirements for providers with a strong track record of...
The Centers for Medicare & Medicaid Services (CMS) has recently made a groundbreaking move by finalizing a rule to streamline...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...
Momentum is building for more state legislators to have health insurance companies pay for biomarker testing for patients with cancer....